Samsung Biologics to open new plant in April 2025

Samsung Biologics, the biotech arm of Korea's Samsung Group, said Wednesday it will open a new biomedicine production facility in April 2025 as part of its plans to deal with rising contract manufacturing demand.

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,Samsung Biologics ,Songdo Incheon ,Pfizer ,Novartis ,Korea Samsung Group ,Samsung Biologic ,Samsung Group ,Bio Campus ,Samsung ,Facility ,Plant ,Ebiomedicine ,Biotech ,April ,Production ,Biologics ,Korea ,He Korea Times ,Orea Times ,Oreatimes ,Orean News In English ,